pE-HWSYGLRPG-OH

Ref. 3D-PP43199

Informations sur le produit

• Nom: pE-HWSYGLRPG-OH
• Synonymes: pE-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-OH

Description

Peptide pE-HWSYGLRPG-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using pE-HWSYGLRPG-OH include the following: Identification of dominant epitopes of synthetic immunocontraceptive vaccines that induce antibodies in dogs. YM Yu Meng, ZWG Zeng WeiGuang, J Pagnon - 2005 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20053145168 A modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope building W Zeng , KJ Horrocks, G Robevska, CY Wong - Journal of Biological , 2011 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)51675-X/abstract Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use in an out-bred population W Zeng , KJ Horrocks, ACL Tan, CY Wong, BY Chua - Vaccine, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X19314355 Reduction of streptavidin RYDS-mediated renal adhesion by site-directed mutagenesis S Murray , A Maraveyas, T Dougan, AC Chu - Biochimica et Biophysica Acta , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304416502001575 Intranasal vaccination with a lipopeptide containing a minimal, conserved M-protein derived peptide and a self-adjuvanting lipid induces both systemic and mucosal MR Batzloff , J Hartas, W Zeng , DC Jackson - International Congress , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0531513105016912 Identification of dominant epitopes of synthetic immunocontraceptive vaccines that induce antibodies in dogs M Yu, W Zeng , J Pagnon, J Walker, S Ghosh, LF Wang - Vaccine, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X05004834 A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses DC Jackson , YF Lau, T Le, A Suhrbier - Proceedings of the , 2004 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0406740101 Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups BY Chua , W Zeng , YF Lau, DC Jackson - Vaccine, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X06008280 Synthesis of toll-like receptor-2 targeting lipopeptides as self-adjuvanting vaccines BY Chua , W Zeng , DC Jackson - Peptide-Based Drug Design, 2008 - Springerhttps://link.springer.com/protocol/10.1007/978-1-59745-419-3_14 Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines BY Chua , M Al Kobaisi , W Zeng - Molecular , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/mp200264m Red-shifted backbone N-H photocaging agents AE Mangubat-Medina, HO Trial, RD Vargas - Organic & , 2020 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2020/ob/d0ob00923g

• Marque: Biosynth